222 related articles for article (PubMed ID: 31102804)
1. Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting.
Choudhury H; Gorain B; Pandey M; Khurana RK; Kesharwani P
Int J Pharm; 2019 Jun; 565():509-522. PubMed ID: 31102804
[TBL] [Abstract][Full Text] [Related]
2. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary drug delivery: a role for polymeric nanoparticles?
d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanogels as drug delivery systems.
Kousalová J; Etrych T
Physiol Res; 2018 Oct; 67(Suppl 2):S305-S317. PubMed ID: 30379552
[TBL] [Abstract][Full Text] [Related]
6. Potentials and challenges of active targeting at the tumor cells by engineered polymeric nanoparticles.
Mukherjee B; Satapathy BS; Mondal L; Dey NS; Maji R
Curr Pharm Biotechnol; 2013; 14(15):1250-63. PubMed ID: 24910012
[TBL] [Abstract][Full Text] [Related]
7. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
8. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
9. Potentials of polymeric nanoparticle as drug carrier for cancer therapy: with a special reference to pharmacokinetic parameters.
Mukherjee B; Das S; Chakraborty S; Satapathy BS; Das PJ; Mondal L; Hossain CM; Dey NS; Chaudhury A
Curr Drug Metab; 2014; 15(6):565-80. PubMed ID: 24909417
[TBL] [Abstract][Full Text] [Related]
10. Dendronized Systems for the Delivery of Chemotherapeutics.
Dockery L; Daniel MC
Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
[TBL] [Abstract][Full Text] [Related]
11. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
Lee WH; Loo CY; Leong CR; Young PM; Traini D; Rohanizadeh R
Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
Kreuter J
Adv Drug Deliv Rev; 2014 May; 71():2-14. PubMed ID: 23981489
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in polymeric micelles for anti-cancer drug delivery.
Biswas S; Kumari P; Lakhani PM; Ghosh B
Eur J Pharm Sci; 2016 Feb; 83():184-202. PubMed ID: 26747018
[TBL] [Abstract][Full Text] [Related]
14. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymers for targeted delivery of anti-cancer drugs.
Doppalapudi S; Jain A; Domb AJ; Khan W
Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
[TBL] [Abstract][Full Text] [Related]
16. The ligand nanoparticle conjugation approach for targeted cancer therapy.
Karra N; Benita S
Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
[TBL] [Abstract][Full Text] [Related]
17. Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.
Elzoghby AO; Abd-Elwakil MM; Abd-Elsalam K; Elsayed MT; Hashem Y; Mohamed O
Curr Pharm Des; 2016; 22(22):3305-23. PubMed ID: 26845323
[TBL] [Abstract][Full Text] [Related]
18. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
[TBL] [Abstract][Full Text] [Related]
19. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules.
Holgado MA; Martin-Banderas L; Alvarez-Fuentes J; Fernandez-Arevalo M; Arias JL
Curr Med Chem; 2012; 19(19):3188-95. PubMed ID: 22612702
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
Sankar R; Ravikumar V
Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
